211
Views
0
CrossRef citations to date
0
Altmetric
Research Article

External validation of integrated genetic-epigenetic biomarkers for predicting incident coronary heart disease

ORCID Icon, , , & ORCID Icon
Pages 1095-1112 | Received 14 Apr 2021, Accepted 07 Jun 2021, Published online: 21 Jun 2021

References

  • Centers for Disease Control . Leading causes of death for 2017. https://www.cdc.gov/heartdisease/facts.htm
  • Wilson PWF , D’agostinoRB , LevyD , BelangerAM , SilbershatzH , KannelWB. Prediction of coronary heart disease using risk factor categories. Circulation97(18), 1837–1847 (1998).
  • Goff DC , Lloyd-JonesDM , BennettGet al. 2013 ACC/AHA guideline on the assessment of cardiovascular risk. Circulation129(2 Suppl. 25), S49–S73 (2014).
  • Thomas GS , VorosS , McphersonJAet al. A blood-based gene expression test for obstructive coronary artery disease tested in symptomatic nondiabetic patients referred for myocardial perfusion imaging the COMPASS study. Circ. Cardiovasc. Genet.6(2), 154–162 (2013).
  • Rosenberg S , ElashoffMR , LieuHDet al. Whole blood gene expression testing for coronary artery disease in nondiabetic patients: major adverse cardiovascular events and interventions in the PREDICT trial. J. Cardiovasc. Transl. Res.5(3), 366–374 (2012).
  • Siemelink MA , ZellerT. Biomarkers of coronary artery disease: the promise of the transcriptome. Curr. Cardiol. Rep.16(8), 513 (2014).
  • Inouye M , AbrahamG , NelsonCPet al. Genomic risk prediction of coronary artery disease in 480,000 adults: implications for primary prevention. J. Am. Coll. Cardiol.72(16), 1883–1893 (2018).
  • Janssens ACJW . Validity of polygenic risk scores: are we measuring what we think we are?Hum. Mol. Genet. doi:10.1093/hmg/ddz205 (2019) ( Epub ahead of print).
  • Martin AR , KanaiM , KamataniY , OkadaY , NealeBM , DalyMJ. Clinical use of current polygenic risk scores may exacerbate health disparities. Nat. Genet.51(4), 584 (2019).
  • Zhang Y , SchöttkerB , FlorathIet al. Smoking-associated DNA methylation biomarkers and their predictive value for all-cause and cardiovascular mortality. Env. Health Perspect.124(1), 67–74 (2015).
  • Sharma P , GargG , KumarAet al. Genome wide DNA methylation profiling for epigenetic alteration in coronary artery disease patients. Gene541(1), 31–40 (2014).
  • Dogan MV , BeachSRH , PhilibertRA. Genetically contextual effects of smoking on genome wide DNA methylation. Am. J. Med. Genet. B Neuropsychiatr. Genet.174(6), 595–607 (2017).
  • Dogan M , BeachS , SimonsR , LendasseA , PenalunaB , PhilibertR. Blood-based biomarkers for predicting the risk for five-year Incident coronary heart disease in the Framingham Heart Study via machine learning. Genes9(12), 641 (2018).
  • Dawber TR , KannelWB , LyellLP. An approach to longitudinal studies in a community: the Framingham Study. Ann. NY Acad. Sci.107, 539–556 (1963).
  • Pidsley R , YWong CC , VoltaM , LunnonK , MillJ , SchalkwykLC. A data-driven approach to preprocessing Illumina 450K methylation array data. BMC Genomics14(1), 1–10 (2013).
  • Triche JRT . FDb.InfiniumMethylation.hg19: annotation package for Illumina Infinium DNA methylation probes. R package version 2.2.0. (2014). https://bioconductor.org/packages/release/data/annotation/html/FDb.InfiniumMethylation.hg19.html
  • Davis S , DuP , BilkeS , TricheJT , MB. methylumi: Handle Illumina methylation data. R package version 2.22.0. (2017). https://www.bioconductor.org/packages/release/bioc/html/methylumi.html
  • Dogan MV , GrumbachIM , MichaelsonJJ , PhilibertRA. Integrated genetic and epigenetic prediction of coronary heart disease in the Framingham Heart Study. PLoS ONE13(1), e0190549 (2018).
  • Purcell S , NealeB , Todd-BrownKet al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet.81(3), 559–575 (2007).
  • Muhlestein JB , MayHT , BairTLet al. Relation of elevated plasma renin activity at baseline to cardiac events in patients with angiographically proven coronary artery disease. Am. J. Cardiol.106(6), 764–769 (2010).
  • Taylor GS , MuhlesteinJB , WagnerGS , BairTL , LiP , AndersonJL. Implementation of a computerized cardiovascular information system in a private hospital setting. Am. Heart J.136(5), 792–803 (1998).
  • Bizouarn F , Karlin-NeumannG. Digital PCR: Methods and Protocols. Springer, NY, USA (2018).
  • Van Rossum G , DrakeFL. Python 3 Reference Manual. CreateSpace, CA, USA (2009).
  • Han J , KamberM , PeiJ. Data Mining: Concepts and Techniques (3rd Edition).Elsevier, Amsterdam, The Netherlands (2011).
  • Pedregosa F , VaroquauxG , GramfortAet al. Scikit-learn: machine learning in Python. J. Mach. Learn. Res.12, 2825–2830 (2011).
  • Dalcín L , PazR , StortiM. MPI for Python. J. Parallel Distrib. Comput.65(9), 1108–1115 (2005).
  • Dalcín L , PazR , StortiM , D’elíaJ. MPI for Python: performance improvements and MPI-2 extensions. J. Parallel Distrib. Comput.68(5), 655–662 (2008).
  • Dalcin LD , PazRR , KlerPA , CosimoA. Parallel distributed computing using Python. Adv. Water Resour.34(9), 1124–1139 (2011).
  • Hanley JA , McneilBJ. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology148(3), 839–843 (1983).
  • Nikpay M , GoelA , WonHHet al. A comprehensive 1,000 Genomes-based genome-wide association meta-analysis of coronary artery disease. Nat. Genet.47(10), 1121–1130 (2015).
  • Bland JM , AltmanDG. The logrank test. BMJ328(7447), 1073 (2004).
  • Davidson-Pilon C . lifelines: Survival analysis in Python. The Journal of Open Source Software4(40), 1317 (2019).
  • Philibert R , DoganM , BeachSRH , MillsJA , LongJD. AHRR methylation predicts smoking status and smoking intensity in both saliva and blood DNA. Am. J. Med. Genet. B Neuropsychiatr. Genet.183(1), 51–60 (2019).
  • Philibert R , MillerS , NoelAet al. A four marker digital PCR toolkit for detecting heavy alcohol consumption and the effectiveness of its treatment. J. Insur. Med.48(1), 90–102 (2019).
  • Rana JS , TabadaGH , SolomonMDet al. Accuracy of the atherosclerotic cardiovascular risk equation in a large contemporary, multiethnic population. J. Am. Coll. Cardiol.67(18), 2118–2130 (2016).
  • Hemann BA , BimsonWF , TaylorAJ. The Framingham Risk Score: an appraisal of its benefits and limitations. Am. Heart Hosp. J.5(2), 91–96 (2007).
  • Myerburg RJ . Sudden cardiac death: exploring the limits of our knowledge. J. Cardiovasc. Electrophysiol.12(3), 369–381 (2001).
  • Fischer A , WarscheidB , WeberW , RadziwillG. Optogenetic clustering of CNK1 reveals mechanistic insights in RAF and AKT signalling controlling cell fate decisions. Sci. Rep.6, 38155 (2016).
  • Hamamdzic D , FenningRS , PatelDet al. Akt pathway is hypoactivated by synergistic actions of diabetes mellitus and hypercholesterolemia resulting in advanced coronary artery disease. Am. J. Physiol. Heart Circ. Physiol.299(3), H699–706 (2010).
  • Frazier-Wood AC , ManichaikulA , AslibekyanSet al. Genetic variants associated with VLDL, LDL and HDL particle size differ with race/ethnicity. Hum. Genet.132(4), 405–413 (2013).
  • Kontush A . HDL particle number and size as predictors of cardiovascular disease. Front. Pharmacol.6, 218 (2015).
  • Shendre A , IrvinMR , WienerHet al. Local ancestry and clinical cardiovascular events among African Americans from the atherosclerosis risk in communities study. J. Am. Heart Assoc.6(4), e004739 (2017).
  • Consortium G . The GTEx Consortium atlas of genetic regulatory effects across human tissues. Science369(6509), 1318–1330 (2020).
  • Dedeurwaerder S , DefranceM , BizetM , CalonneE , BontempiG , FuksF. A comprehensive overview of Infinium HumanMethylation450 data processing. Brief. Bioinform.15(6), 929–941 (2013).
  • The Blueprint Consortium , BockC , HalbritterFet al.Quantitative comparison of DNA methylation assays for biomarker development and clinical applications. Nature Biotechnol.34, 726 (2016).
  • Kruppa J , SiegM , RichterG , PohrtA. Estimands in epigenome-wide association studies. Clin. Epigenetics13(1), 98 (2021).
  • Taryma-Leśniak O , SokolowskaKE , WojdaczTK. Current status of development of methylation biomarkers for in vitro diagnostic IVD applications. Clin. Epigenetics12(1), 100 (2020).
  • Jiang D , SunM , YouLet al. DNA methylation and hydroxymethylation are associated with the degree of coronary atherosclerosis in elderly patients with coronary heart disease. Life Sci.224, 241–248 (2019).
  • Philibert W , AndersenAM , HoffmanEA , PhilibertR , DoganM. The reversion of DNA methylation at coronary heart disease risk loci in response to prevention therapy. Processes9(4), 699 (2021).
  • Weidmann H , Touat-HamiciZ , DurandHet al. SASH1, a new potential link between smoking and atherosclerosis. Atherosclerosis242(2), 571–579 (2015).
  • Hou K , BurchKS , MajumdarAet al. Accurate estimation of SNP-heritability from biobank-scale data irrespective of genetic architecture. Nat. Genet.51(8), 1244–1251 (2019).
  • Imperiale TF , RansohoffDF , ItzkowitzSHet al. Multitarget stool DNA testing for colorectal-cancer screening. N. Engl. J. Med.370(14), 1287–1297 (2014).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.